Amarin Corp Plc (AMRN)

[BioInvestor3]

Capt you know what's funny?

Here we are on a stock message board saying what Amarin should do or not do.

The lawyers and consulting firms I mentioned that specialize in the approval process, they have many years of experience with the FDA, and many of them in fact worked for the FDA (FDA lawyers or in regulatory).

Companies hire them, they won't listen to anyone on this board lol.

Look at BSC, formerly Valeant. They just lost a patent case on their most important drug Xifaxan.
Previously about 5-6 years ago I thought they had settled with a generic challenger, or this is a new one, I don't know.
But this is interesting because Xifaxan is approved for 3 indications, TD, IBS-D, and HE. Of these by far the IBS-D indication is the most important one, and this is the one they lost, the other 2 are intact.
Interesting case to follow, BSC of course will appeal but the stock has been mortally wounded.